Treatment for alcohol use disorder (AUD) has the potential to improve health and quality of life. Little is known about disparities in AUD treatment utilization at the intersection of race and gender. We examined disparities in AUD treatment utilization among those diagnosed with AUD in a community sample, by race, ethnicity, and gender, and whether disparities varied by insurance. We also examined whether criminal legal history and socioeconomic status moderated disparities in treatment.
Methods:
We used data from the nationally representative 2017 to 2019 National Survey on Drug Use and Health, the most recent 3-year period available. The analytic sample included noninstitutionalized adults aged 18 to 64 who met criteria for past year AUD and identified as White, Black, or Latinx (n = 7782). We examined disparities in AUD treatment utilization by race, ethnicity, and gender subgroup and by insurance status, estimating weighted logistic regressions, and adjusting for indicators of clinical need in concordance with the Institute of Medicine definition of healthcare disparity.
Results:
Only 5.4% of adults with AUD in the United States utilized AUD treatment in the past year. AUD treatment utilization did not significantly differ between White males and other racial, ethnic, and gender groups; however, we did identify disparities among Medicaid enrollees and those who were uninsured. Among Medicaid enrollees, Latinx females (3.2%) had lower treatment utilization than White males (9.3%, P < .05). Among uninsured individuals, Latinx males (1.8%) had lower treatment utilization than White males (6.2%, P < .05).
Conclusions:
AUD treatment utilization was extremely low among adults in the United States aged 18 to 64 who met criteria for AUD. Ethnic and gender disparities in treatment utilization were revealed when examining differences in AUD treatment utilization by insurance status. Strategies for improving access to AUD treatment that address structural barriers to care are needed and should consider targeted approaches for Medicaid enrollees and those uninsured.
Center for Behavioral Health Statistics and Quality. Results from the 2022 National Survey on Drug Use and Health: Detailed Tables. Substance Abuse and Mental Health Services Administration. 2023. Accessed November 29, 2023. https://www.samhsa.gov/data/report/2022-nsduh-detailed-tables
2.
DutraLStathopoulouGBasdenSLLeyroTMPowersMBOttoMW. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry. 2008;165(2):179-187. doi:10.1176/appi.ajp.2007.06111851
3.
JonasDEAmickHRFeltnerC, et al. Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. JAMA. 2014;311(18):1889-1900. doi:10.1001/jama.2014.3628
4.
JørgensenCHPedersenBTønnesenH. The efficacy of disulfiram for the treatment of alcohol use disorder. Alcohol Clin Exp Res. 2011;35(10):1749-1758. doi:10.1111/j.1530-0277.2011.01523.x
5.
WitkiewitzKLittenRZLeggioL. Advances in the science and treatment of alcohol use disorder. Sci Adv. 2019;5(9):eaax4043. doi:10.1126/sciadv.aax4043
6.
BandaraSNSamplesHCrumRMSalonerB. Is screening and intervention associated with treatment receipt among individuals with alcohol use disorder? Evidence from a national survey. J Subst Abuse Treat. 2018;92:85-90. doi:10.1016/j.jsat.2018.06.009
7.
MuliaNTamTWSchmidtLA. Disparities in the use and quality of alcohol treatment services and some proposed solutions. Psychiatr Serv. 2014;65(5):626-633. doi:10.1176/appi.ps.201300188
8.
Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2021 National Survey on Drug Use and Health. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. 2022. Accessed September 27, 2023. https://www.samhsa.gov/data/report/2021-nsduh-annual-national-report
9.
CookBLAlegríaM. Racial-ethnic disparities in substance abuse treatment: the role of criminal history and socioeconomic status. Psychiatr Serv. 2011;62(11):1273-1281. doi:10.1176/ps.62.11.pss6211_1273
10.
GilbertPAProGZemoreSEMuliaNBrownG. Gender differences in use of alcohol treatment services and reasons for nonuse in a national sample. Alcohol Clin Exp Res. 2019;43(4):722-731. doi:10.1111/acer.13965
11.
MuliaNBensleyKM. Alcohol-related disparities among women: evidence and potential explanations. Alcohol Res Curr Rev. 2020;40(2):9. doi:10.35946/arcr.v40.2.09
12.
Mulvaney-DayNDeAngeloDChenCNCookBLAlegríaM. Unmet need for treatment for substance use disorders across race and ethnicity. Drug Alcohol Depend. 2012;125(Suppl 11):S44-S50. doi:10.1016/j.drugalcdep.2012.05.005
13.
ZemoreSEMurphyRDMuliaN, et al. A moderating role for gender in racial/ethnic disparities in alcohol services utilization: results from the 2000-2010 National Alcohol Surveys. Alcohol Clin Exp Res. 2014;38(8):2286-2296. doi:10.1111/acer.12500
14.
ChartierKGVaethPACCaetanoR. Focus on: ethnicity and the social and health harms from drinking. Alcohol Res Curr Rev. 2013;35(2):229-237.
15.
CollinsSE. Associations between socioeconomic factors and alcohol outcomes. Alcohol Res Curr Rev. 2016;38(1):83-94.
16.
KeyesKMLiuXCCerdaM. The role of race/ethnicity in alcohol-attributable injury in the United States. Epidemiol Rev. 2012;34(1):89-102. doi:10.1093/epirev/mxr018
17.
WitbrodtJMuliaNZemoreSEKerrWC. Racial/ethnic disparities in alcohol-related problems: differences by gender and level of heavy drinking. Alcohol Clin Exp Res. 2014;38(6):1662-1670. doi:10.1111/acer.12398
18.
KarayeIMMalekiNHassanNYunusaI. Trends in alcohol-related deaths by sex in the US, 1999-2020. JAMA Netw Open. 2023;6(7):e2326346. doi:10.1001/jamanetworkopen.2023.26346
19.
SpillaneSShielsMSBestAF, et al. Trends in alcohol-induced deaths in the United States, 2000-2016. JAMA Netw Open. 2020;3(2):e1921451. doi:10.1001/jamanetworkopen.2019.21451
20.
AdamsRSMcKettaSCJagerJStewartMTKeyesKM. Cohort effects of women’s mid-life binge drinking and alcohol use disorder symptoms in the United States: impacts of changes in timing of parenthood. Addiction. 2023;118(10):1932-1941. doi:10.1111/add.16262
21.
GruczaRASherKJKerrWC, et al. Trends in adult alcohol use and binge drinking in the early 21st-century United States: a meta-analysis of 6 national survey series. Alcohol Clin Exp Res. 2018;42(10):1939-1950. doi:10.1111/acer.13859
22.
KeyesKMJagerJMal-SarkarTPatrickMERutherfordCHasinD. Is there a recent epidemic of women’s drinking? A critical review of national studies. Alcohol Clin Exp Res. 2019;43(7):1344-1359. doi:10.1111/acer.14082
23.
SalonerBAkosa AntwiYMacleanJCCookB. Access to health insurance and utilization of substance use disorder treatment: evidence from the Affordable Care Act dependent coverage provision. Health Econ. 2018;27(1):50-75. doi:10.1002/hec.3482
24.
SalonerBMacleanJC. Specialty substance use disorder treatment admissions steadily increased in the four years after Medicaid expansion. Health Aff (Millwood). 2020;39(3):453-461. doi:10.1377/hlthaff.2019.01428
25.
StockdaleSETangLZhangLBelinTRWellsKB. The effects of health sector market factors and vulnerable group membership on access to alcohol, drug, and mental health care. Health Serv Res. 2007;42(3 Pt 1):1020-1041. doi:10.1111/j.1475-6773.2006.00636.x
AbrahamAJAndrewsCMHarrisSJWestlakeMMGroganCM. Coverage and prior authorization policies for medications for opioid use disorder in Medicaid managed care. JAMA Health Forum. 2022;3(11):e224001. doi:10.1001/jamahealthforum.2022.4001
MarkTLLevitKRYeeTChowCM. Spending on mental and substance use disorders projected to grow more slowly than all health spending through 2020. Health Aff (Millwood). 2014;33(8):1407-1415. doi:10.1377/hlthaff.2014.0163
32.
MarkTLYeeTLevitKRCamacho-CookJCutlerECarrollCD. Insurance financing increased for mental health conditions but not for substance use disorders, 1986-2014. Health Aff (Millwood). 2016;35(6):958-965. doi:10.1377/hlthaff.2016.0002
33.
BaileyZDKriegerNAgénorMGravesJLinosNBassettMT. Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017;389(10077):1453-1463. doi:10.1016/S0140-6736(17)30569-X
34.
BaileyZDFeldmanJMBassettMT. How structural racism works—Racist policies as a root cause of U.S. racial health inequities. N Engl J Med. 2021;384(8):768-773. doi:10.1056/NEJMms2025396
35.
LewisBHoffmanLGarciaCCNixonSJ. Race and socioeconomic status in substance use progression and treatment entry. J Ethn Subst Abuse. 2018;17(2):150-166. doi:10.1080/15332640.2017.1336959
36.
BroomeKMKnightKHillerMLDwayne SimpsonD. Drug treatment process indicators for probationers and prediction of recidivism. J Subst Abuse Treat. 1996;13(6):487-491. doi:10.1016/S0740-5472(96)00097-9
37.
LurigioAJ. Drug treatment availability and effectiveness: studies of the general and criminal justice populations. Crim Justice Behav. 2000;27(4):495-528. doi:10.1177/0093854800027004005
38.
ChandlerRKFletcherBWVolkowND. Treating drug abuse and addiction in the criminal justice system: improving public health and safety. JAMA. 2009;301(2):183-190. doi:10.1001/jama.2008.976
39.
PetersRHKearnsWDMurrinMRDolenteASMayRL. Examining the effectiveness of in-jail substance abuse treatment. J Offender Rehabil. 1993;19(3-4):1-39. doi:10.1300/J076v19n03_01
40.
Institute of Medicine. Unequal treatment: confronting racial and ethnic disparities in health care. National Academies Press; 2003.
41.
BrownTHRichardsonLJHargroveTWThomasCS. Using multiple-hierarchy stratification and life course approaches to understand health inequalities: the intersecting consequences of race, gender, ses, and age. J Health Soc Behav. 2016;57(2):200-222. doi:10.1177/0022146516645165
42.
CummingsJLBraboy JacksonP. Race, gender, and SES disparities in self-assessed health, 1974-2004. Res Aging. 2008;30(2):137-167. doi:10.1177/0164027507311835
43.
HargroveTW. Intersecting social inequalities and body mass index trajectories from adolescence to early adulthood. J Health Soc Behav. 2018;59(1):56-73. doi:10.1177/0022146517746672
44.
HudsonDLPutermanEBibbins-DomingoKMatthewsKAAdlerNE. Race, life course socioeconomic position, racial discrimination, depressive symptoms and self-rated health. Soc Sci Med 1982. 2013;97:7-14. doi:10.1016/j.socscimed.2013.07.031
Substance Abuse and Mental Health Services Administration. SAMHSA Data. Accessed July 15, 2024. https://www.samhsa.gov/data/
47.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed.American Psychiatric Association; 1994.
48.
Center for Behavioral Health Statistics and Quality. 2019 National Survey on Drug Use and Health public use file codebook. Substance Abuse and Mental Health Services Administration; 2019.
KesslerRCBarkerPRColpeLJ, et al. Screening for serious mental illness in the general population. Arch Gen Psychiatry. 2003;60(2):184-189. doi:10.1001/archpsyc.60.2.184
ValentinoLYadonN. Intersectional wealth gaps: Contemporary and historical trends in wealth stratification among single households by race and gender. Soc Curr. 2023;10(1):3-16. doi:10.1177/23294965221139845
SommersBDBlendonRJOravEJEpsteinAM. Changes in utilization and health among low-income adults after medicaid expansion or expanded private insurance. JAMA Intern Med. 2016;176(10):1501-1509. doi:10.1001/jamainternmed.2016.4419
63.
FoxAMFengWZeitlinJHowellEA. Trends in state Medicaid eligibility, enrollment rules, and benefits. Health Aff (Millwood). 2020;39(11):1909-1916. doi:10.1377/hlthaff.2019.01350
64.
SugarSPetersCLewNDSommersBD. Medicaid churning and continuity of care: evidence and policy considerations before and after the COVID-19 pandemic. Assistant Secretary for Planning and Evaluation, Office of Health Policy; 2021. Accessed November 1, 2023. https://aspe.hhs.gov/sites/default/files/private/pdf/265366/medicaid-churning-ib.pdf
65.
AndrewsCMPollackHAAbrahamAJ, et al. Medicaid coverage in substance use disorder treatment after the Affordable Care Act. J Subst Abuse Treat. 2019;102:1-7. doi:10.1016/j.jsat.2019.04.002
66.
MacleanJCSalonerB. The effect of public insurance expansions on substance use disorder treatment: Evidence from the Affordable Care Act. J Policy Anal Manage. 2019;38(2):366-393. doi:10.1002/pam.22112
67.
CourtemancheCMartonJUkertBYelowitzAZapataD. Early effects of the Affordable Care Act on health care access, risky health behaviors, and self-assessed health. South Econ J. 2018;84(3):660-691. doi:10.1002/soej.12245
WenHWilkASDrussBGCummingsJR. Medicaid acceptance by psychiatrists before and after Medicaid expansion. JAMA Psychiatry. 2019;76(9):981-983. doi:10.1001/jamapsychiatry.2019.0958
70.
LuoQBodasMVichareA, et al. Primary care provider Medicaid participation across the United States, 2016. J Health Care Poor Underserved. 2023;34(2):703-718. doi:10.1353/hpu.2023.0059
71.
AbrahamAJAndrewsCMHarrisSJFriedmannPD. Availability of medications for the treatment of alcohol and opioid use disorder in the USA. Neurother J Am Soc Exp Neurother. 2020;17(1):55-69. doi:10.1007/s13311-019-00814-4
FusaroVALevyHGShaeferHL. Racial and ethnic disparities in the lifetime prevalence of homelessness in the United States. Demography. 2018;55(6):2119-2128. doi:10.1007/s13524-018-0717-0
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
